Physician profile
Michael Thorpe
NPI 1730413717
$27,900.60
in general payments reported to CMS, 2019-2025
26 companies · $6,766 in 2025
The $6,766 reported for 2025 was more than what 93% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,062 · 2020: $12K · 2021: $1,164 · 2022: $680 · 2023: $321 · 2024: $2,080 · 2025: $6,766.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $4,333 · Travel and Lodging: $2,656 · Food and Beverage: $2,177.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $4,333.33 |
| Travel and Lodging | $2,655.95 |
| Food and Beverage | $2,176.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $11,735.43 | 2019-2021 | |
| Angiodynamics, INC. | $4,423.13 | 2022-2025 | Venacure 1470 Pro, Venacure 1470 Pro |
| Medical Device Business Services, INC. | $3,379.50 | 2019-2025 | Linx Reflux Management System |
| Covidien LP | $2,698.55 | 2019-2020 | |
| Medtronic, INC. | $1,812.18 | 2021-2025 | Venaseal, Closurefast, Closurerfg |
| Convatec INC. | $1,554.27 | 2024-2025 | |
| Ethicon US, LLC | $740.09 | 2019-2025 | Linx Reflux Management System |
| Davol INC. | $293.19 | 2019-2025 | Phasix Mesh |
| Boston Scientific Corporation | $271.24 | 2022-2024 | Varithena Administration Pack |
| Allergan, INC. | $185.50 | 2019-2022 | |
| Intuitive Surgical, INC. | $167.77 | 2019-2020 | |
| Kerecis Limited | $131.47 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Mimedx Group, INC. | $82.32 | 2025 | |
| Tactile Systems Technology INC | $79.84 | 2024-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Zimmer Biomet Holdings, INC. | $66.08 | 2020-2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $63.04 | 2022-2023 | Cimzia |
| Tela Bio, INC. | $33.38 | 2019 | |
| Endogastric Solutions, INC | $31.89 | 2019 | |
| Biogen, INC. | $23.75 | 2023 | Spinraza |
| Bard Peripheral Vascular, INC. | $23.29 | 2022 | |
| Lexington Medical, INC. | $23.09 | 2022 | |
| Triad Life Sciences INC. | $18.85 | 2022 | |
| Kci USA, INC. | $18.76 | 2022 | |
| Amgen INC. | $17.54 | 2022 | |
| Galderma Laboratories, L.P. | $14.96 | 2022 | |
| Strata Skin Sciences, INC. | $11.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Thorpe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.